135 related articles for article (PubMed ID: 3547024)
1. Induction of specific macrophage cytotoxicity.
De Weger RA; Den Otter W
Methods Enzymol; 1986; 132():531-6. PubMed ID: 3547024
[No Abstract] [Full Text] [Related]
2. Identification of gamma-interferon as a murine macrophage-activating factor for tumor cytotoxicity.
Schreiber RD
Contemp Top Immunobiol; 1984; 13():171-98. PubMed ID: 6428805
[No Abstract] [Full Text] [Related]
3. Macrophage activation for tumor cytotoxicity: genetic variation in macrophage tumoricidal capacity among mouse strains.
Boraschi D; Meltzer MS
Cell Immunol; 1979 Jun; 45(1):188-94. PubMed ID: 378423
[No Abstract] [Full Text] [Related]
4. Modulation of the tumoricidal function of activated macrophages by bacterial endotoxin and mammalian macrophage activation factor (s).
Hibbs JB; Weinberg JB; Chapman HA
Adv Exp Med Biol; 1979; 121B():433-53. PubMed ID: 232620
[No Abstract] [Full Text] [Related]
5. The role of a cytophilic factor from challenged immune peritoneal lymphocytes in specific macrophage cytotoxicity.
Pels E; den Otter W
Cancer Res; 1974 Nov; 34(11):3089-94. PubMed ID: 4423930
[No Abstract] [Full Text] [Related]
6. Regulation of macrophage functions by interferon.
Boraschi D; Pasqualetto E; Ghezzi P; Salmona M; Niederhuber JE; Tagliabue A
Adv Exp Med Biol; 1982; 155():519-24. PubMed ID: 6297269
[No Abstract] [Full Text] [Related]
7. Susceptibility of malignant and normal target cells to the cytotoxic action of bone-marrow macrophages activated in vitro with the macrophage cytotoxicity factor (MCF).
Lohmann-Matthes ML; Kolb B; Meerpohl HG
Cell Immunol; 1978 Dec; 41(2):231-9. PubMed ID: 729007
[No Abstract] [Full Text] [Related]
8. Activating factors for nonspecific and antibody-dependent cytotoxicity by human and murine mononuclear phagocytes.
Ralph P
Lymphokine Res; 1984; 3(4):153-61. PubMed ID: 6208440
[No Abstract] [Full Text] [Related]
9. Host macrophages are involved in systemic adoptive immunity against tumors.
Van Loveren H; Snoek M; den Otter W
Experientia; 1982 Apr; 38(4):488-90. PubMed ID: 6896309
[No Abstract] [Full Text] [Related]
10. The role of host lymphocytes and host macrophages in antitumor reactions after injection of sensitized lymphocytes and tumor target cells into naive mice.
Dullens HF; Vuist W; Van der Maas M; Den Otter W
Cancer Immunol Immunother; 1986; 23(2):113-8. PubMed ID: 3536093
[TBL] [Abstract][Full Text] [Related]
11. The induction of lymphocytes with the capacity to render macrophages cytotoxic in an allogeneic murine system.
De Weger RA; Pels E; Den Otter W
Immunology; 1982 Nov; 47(3):541-50. PubMed ID: 6215342
[TBL] [Abstract][Full Text] [Related]
12. Lymphocyte induced macrophage cytotoxicity: characterization of the macrophage cytotoxicity-inducing lymphocyte.
Pels E; de Weger RA; den Otter W
Immunobiology; 1984 Jan; 166(1):84-95. PubMed ID: 6201434
[TBL] [Abstract][Full Text] [Related]
13. D-Mannose as a component of the macrophage surface receptor for macrophage-activating factor(MAF) in mice.
Yamamoto S; Tokunaga T
Cell Immunol; 1981 Jul; 61(2):319-31. PubMed ID: 7018700
[No Abstract] [Full Text] [Related]
14. Macrophages as cytotoxic effector cells.
Lohmann-Matthes ML; Lang H; Sun D
Immunobiology; 1982 Apr; 161(3-4):401-7. PubMed ID: 7047379
[TBL] [Abstract][Full Text] [Related]
15. Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.
Nakajima H; Fujiwara H; Takai Y; Izumi Y; Sano S; Tsuchida T; Hamaoka T
J Immunol; 1985 Sep; 135(3):2199-205. PubMed ID: 3894520
[TBL] [Abstract][Full Text] [Related]
16. Characterization of macrophage activation factor, a lymphokine that causes macrophages to become cytotoxic for tumor cells.
Leonard EJ; Ruco LP; Meltzer MS
Cell Immunol; 1978 Dec; 41(2):347-57. PubMed ID: 31981
[No Abstract] [Full Text] [Related]
17. Immune reactivity in SL2 lymphoma-bearing mice compared with SL2-immunized mice.
De Weger RA; Wilbrink B; Moberts RM; Mans D; Oskam R; Den Otter W
Cancer Immunol Immunother; 1987; 24(1):25-36. PubMed ID: 3493070
[TBL] [Abstract][Full Text] [Related]
18. Functional activities of the NCTC 1469 macrophage-like cell line: comparison of the NCTC 1469 cell line with various other macrophage-like cell lines.
De Weger RA; Van Loveren H; Van Basten CD; Oskam R; Van Der Zeijst BA; Den Otter W
J Reticuloendothel Soc; 1983 Jan; 33(1):55-66. PubMed ID: 6687612
[No Abstract] [Full Text] [Related]
19. Eradication of lymphoma cells with allogeneic immune peritoneal cells.
Dullens HF; den Otter W
Experientia; 1973 Apr; 29(4):479-81. PubMed ID: 4708353
[No Abstract] [Full Text] [Related]
20. Role of macrophages in tumour immunity. I. Co-operation between macrophages and lymphoid cells in syngeneic tumour immunity.
Evans R; Alexander P
Immunology; 1972 Oct; 23(4):615-26. PubMed ID: 5084104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
